Banco BTG Pactual S.A. Has $464,000 Stock Position in UnitedHealth Group Incorporated $UNH

Banco BTG Pactual S.A. boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 67.8% during the first quarter, Holdings Channel reports. The institutional investor owned 886 shares of the healthcare conglomerate’s stock after acquiring an additional 358 shares during the quarter. Banco BTG Pactual S.A.’s holdings in UnitedHealth Group were worth $464,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently bought and sold shares of the company. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at $26,000. Bayforest Capital Ltd raised its holdings in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd raised its holdings in shares of UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 50 shares during the last quarter. Kapitalo Investimentos Ltda bought a new position in shares of UnitedHealth Group in the fourth quarter valued at about $41,000. Finally, Copia Wealth Management bought a new position in shares of UnitedHealth Group in the fourth quarter valued at about $42,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the subject of several recent research reports. Hsbc Global Res cut UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. TD Securities reiterated a “hold” rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Wells Fargo & Company decreased their price objective on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Robert W. Baird reaffirmed an “underperform” rating and set a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Finally, TD Cowen downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target for the company. in a research report on Monday, May 19th. Fifteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $367.71.

Insider Activity

In other news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares of the company’s stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.28% of the company’s stock.

UnitedHealth Group Stock Down 1.5%

UNH stock opened at $303.77 on Wednesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a market capitalization of $275.12 billion, a price-to-earnings ratio of 13.16, a PEG ratio of 1.99 and a beta of 0.43. The business’s fifty day moving average price is $289.03 and its two-hundred day moving average price is $393.55. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm’s quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s dividend payout ratio is 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.